Thermoplastic Polyolefin Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 – 2024

Posted By: Alok Kumar May 18, 2017

The global intravenous immunoglobulin (IVIG) market is anticipated to register a strong 8.5% CAGR from 2016 to 2024, with the opportunity in the market slated to reach US$14.92 bn by 2024. This positive stride can be attributed to the many advantages IVIG provides to clinicians around the globe. Improving healthcare infrastructure across developing economies and technological advancements in production and purification methods for IVIG will ensure that the market continues to expand at a healthy pace in the coming years.

Request for Sample Report: http://www.mrrse.com/sample/2162

Geographically, North America is the clear leader in the global intravenous immunoglobulin market and is slated to exhibit strong growth over the course of the forecast period, powered by the U.S. This lucrative IVIG market has been witnessing rising demand for intravenous immunoglobulin infusion therapy owing to growing prevalence of various immunological disorders and increasing geriatric population. Other factors benefiting the U.S. IVIG market include major advancements in technology, a strong economy, and abundant supply of plasma. In addition to this, increased investments in R&D and favorable reimbursement policies will continue to support the North America intravenous immunoglobulin market. In order to boost plasma donation, the U.S. FDA has been approving payments to plasma donors across the country, which has enabled it to become a self-reliant and key global exporter of plasma-derived products.

Europe is also major market for IVIG and owes its growth to an expanding patient and geriatric pool. As a developed region, Europe has been just as accepting of new products and innovative technologies as North America. Various clinical trials to test the viability and efficacy of new IVIG products and therapies have also boosted this regional market.

Common Side Effects of IVIG Likely to Deter Patient and Clinical Adoption

One of the major factors limiting the widespread acceptance of intravenous immunoglobulin is the side effects associated with it. Common side effects include muscle cramps, flushing, chills, nausea, fever, vomiting, chest pain, back/joint pain, sudden cough, shortness of breath, and wheezing. This can not only discourage patients from continuing IVIG therapies but also compel clinicians to choose alternate therapies.

The higher cost of plasma collection and manufacturing processes is another factor hampering the growth of the intravenous immunoglobulin market. Conventional methods of pharmaceutical manufacturing and processing are relatively cheaper as they do not require sophisticated equipment for collection, purification, and storage.

Consolidated Nature of Vendor Landscape Results in Intense Competition

The nature of the global intravenous immunoglobulin market in extremely consolidated and the leading four companies together accounted for massive 70.0% share in 2015. Grifols S.A., CSL Behring LLC, Baxalta Incorporated, Octapharma AG, and Kedrion S.p.A. have been dominating the scene, with Grifols leading the pack.

Strong geographic penetration is the main factor driving the company to emerge as the largest contributor to the worldwide IVIG market in terms of revenue. In January 2015, the company received FDA approval to set up a purification plant for IVIG 10%, further strengthening its Gamunex and Flebogamma brands. The firm also invested US$360 mn in March 2016 in the expansion of one of its plasma products manufacturing units.

Browse Full Report with TOC: http://www.mrrse.com/intravenous-immunoglobulin-market

CSL Behring, on the other, owes its success to an extensive product portfolio. In March 2016, the company received FDA approval for IDELVION, the first of its kind commercially available factor IX therapy.

About Us

Market Research Reports Search Engine (MRRSE) is an industry-leading database of market intelligence reports. MRRSE is driven by a stellar team of research experts and advisors trained to offer objective advice. Our sophisticated search algorithm returns results based on the report title, geographical region, publisher, or other keywords.

MRRSE partners exclusively with leading global publishers to provide clients single-point access to top-of-the-line market research. MRRSE’s repository is updated every day to keep its clients ahead of the next new trend in market research, be it competitive intelligence, product or service trends or strategic consulting.

Contact

State Tower
90, State Street
Suite 700
Albany, NY – 12207
United States Telephone: +1-518-730-0559
Email: sales@mrrse.com
Follow Us on LinkedIn-https://www.linkedin.com/company/mrrse
Follow Us On Twitter-https://twitter.com/MRRSEmrrse

Thermoplastic Polyolefin Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 – 2024

TOPICS:Thermoplastic Polyolefin Industry Analysis Thermoplastic Polyolefin Market Thermoplastic Polyolefin Market Forecast Thermoplastic Polyolefin Market Research Thermoplastic Polyolefin Market Research Reports

Posted By: Alok Kumar May 18, 2017

Driven by the increasing scope of application across construction and automotive sectors, the global thermoplastic polyolefin (TPO) market is projected to report strong growth in the coming years. According to recent studies, growth witnessed across emerging nations such as India and China will provide major impetus to the market. On the flip side, the market is witnessing threat from high capacity to demand ratio and the continuously fluctuating raw material prices.a

Request for Sample Report: http://www.mrrse.com/sample/2164

Over the course of the next few years, the automotive industry is expected to remain one of the major end users accounting for a significant share in the Global Thermoplastic Polyolefin Market.

The industry has emerged as a leading segment in the overall market and is expected to continue dominating in terms of both volume and revenue in the next few years. Other application sectors, which are expected to showcase attractive opportunities are fibers and tapes, molds, films and sheet, in packaging, construction, and medical sectors.

In addition, the pace of gains will accelerate in response to the increasing efforts to explore its utility as feedstock. Spurred by these factors, the global TPO market will continue exhibiting robust growth in the coming years. The market is expected gain increased traction due to use in emerging applications such as healthcare, construction, and packaging.

Market to Gain Impetus from Stringent Environmental Regulation

In order to cohere with stringent regulations aimed at curbing pollutions, an increasing number of industries such as construction and automotive are compelled to choose TPO over PVC. This has emerged as a crucial market driver, which will continue aiding the market’s expansion through the forthcoming years. Phthalates present in PVC are considered harmful to environment, which is curbing their use subsequently fuelling opportunities for the TPO market. Furthermore, TPO similar to other members in the family of thermoplastic elastomers include TPU and TPV, which have rubber-like properties but process like polymers. This property makes it highly suitable for use in high-performance applications across various industries. The market therefore witnesses strong growth opportunities.

Emerging Nations in Asia Pacific to Exhibit Lucrative Opportunities

Regionally, the market is expected to witness high demand in North America, as it boasts a sophisticated industrial infrastructure. The region holds dominance across prominent sectors such as automotive and medical, which will aid expansion of the TPO market in North America. Besides this Asia Pacific will exhibit lucrative opportunities for the market. The rapid industrialization across emerging nations such as India and China, will support the market’s growth in Asia Pacific. Furthermore, the market will continue gaining from the increasing demand in industries across Europe.

Browse Full Report with TOC: http://www.mrrse.com/thermoplastic-polyolefins

A few companies, which will gain from the aforementioned factors are Exxon Mobil Corporation, Lyondell Basell Industries Holding B.V., Mitsubishi Chemical Holding Corporation, Mitsui Chemicals, Inc., Chevron Phillips Chemical Company LLC, A.Schulman, Borealis AG, PolyOne Corporation, and INEOS Group Limited. In order to expand their geographic footprint a majority of these companies are looking towards opportunities in emerging nations. Policies adopted by these enterprises will also have a considerably influence on the overall thermoplastic polyolefin market.

About Us

Contact